APA

van der Bijl A. E., Breedveld F. C., Antoni C. E., Kalden J. R., Kary S., Burmester G. R., Beckmann C., Unnebrink K. & Kupper H. (20090108). An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody status. : Clinical rheumatology.

Chicago

van der Bijl Arie E, Breedveld Ferdinand C, Antoni Christian E, Kalden Joachim R, Kary Sonja, Burmester Gerd R, Beckmann Christina, Unnebrink Kristina and Kupper Hartmut. 20090108. An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody status. : Clinical rheumatology.

Harvard

van der Bijl A. E., Breedveld F. C., Antoni C. E., Kalden J. R., Kary S., Burmester G. R., Beckmann C., Unnebrink K. and Kupper H. (20090108). An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody status. : Clinical rheumatology.

MLA

van der Bijl Arie E, Breedveld Ferdinand C, Antoni Christian E, Kalden Joachim R, Kary Sonja, Burmester Gerd R, Beckmann Christina, Unnebrink Kristina and Kupper Hartmut. An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody status. : Clinical rheumatology. 20090108.